Search research articles
Contact Us
Filters
Showing results (601-610 of 646) with videos related to
Page
of 65
Sort By:
Infection
|
July 6, 2021
Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)
Jakob J Malin, Christoph D Spinner, Uwe Janssens, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
July 28, 2019
Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis
Jorge F Maspero, Constance H Katelaris, William W Busse, et al.
The Journal of Allergy and Clinical Immunology
|
February 6, 2021
Lung function fluctuation patterns unveil asthma and COPD phenotypes unrelated to type 2 inflammation
Edgar Delgado-Eckert, Anna James, Delphine Meier-Girard, et al.
ERJ Open Research
|
February 18, 2025
Neutrophilic inflammation in sputum or blood does not define a clinically distinct asthma phenotype in ATLANTIS
Pauline J M Kuks, Tessa M Kole, Monica Kraft, et al.
Infection
|
August 20, 2021
Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)
Jakob J Malin, Christoph D Spinner, Uwe Janssens, et al.
Pneumologie (Stuttgart, Germany)
|
September 2, 2021
[S1 Guideline Post-COVID/Long-COVID]
Andreas Rembert Koczulla, Tobias Ankermann, Uta Behrends, et al.
The New England Journal of Medicine
|
May 22, 2018
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
Mario Castro, Jonathan Corren, Ian D Pavord, et al.
Eclinicalmedicine
|
July 25, 2022
Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study
Thomas Bahmer, Christoph Borzikowsky, Wolfgang Lieb, et al.
Pneumologie (Stuttgart, Germany)
|
March 17, 2021
[Guideline for the Diagnosis and Treatment of Asthma - Addendum 2020 - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology]
R Buhl, R Bals, X Baur, et al.
The European Respiratory Journal
|
February 2, 2008
Outcomes for COPD pharmacological trials: from lung function to biomarkers
M Cazzola, W MacNee, F J Martinez, et al.
Page
of 65
Search research articles
Search
Showing results (601-610 of 646) with videos related to
Sort By:
Page
of 65
Infection
|
July 6, 2021
Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)
Jakob J Malin, Christoph D Spinner, Uwe Janssens, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
July 28, 2019
Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis
Jorge F Maspero, Constance H Katelaris, William W Busse, et al.
The Journal of Allergy and Clinical Immunology
|
February 6, 2021
Lung function fluctuation patterns unveil asthma and COPD phenotypes unrelated to type 2 inflammation
Edgar Delgado-Eckert, Anna James, Delphine Meier-Girard, et al.
ERJ Open Research
|
February 18, 2025
Neutrophilic inflammation in sputum or blood does not define a clinically distinct asthma phenotype in ATLANTIS
Pauline J M Kuks, Tessa M Kole, Monica Kraft, et al.
Infection
|
August 20, 2021
Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)
Jakob J Malin, Christoph D Spinner, Uwe Janssens, et al.
Pneumologie (Stuttgart, Germany)
|
September 2, 2021
[S1 Guideline Post-COVID/Long-COVID]
Andreas Rembert Koczulla, Tobias Ankermann, Uta Behrends, et al.
The New England Journal of Medicine
|
May 22, 2018
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
Mario Castro, Jonathan Corren, Ian D Pavord, et al.
Eclinicalmedicine
|
July 25, 2022
Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study
Thomas Bahmer, Christoph Borzikowsky, Wolfgang Lieb, et al.
Pneumologie (Stuttgart, Germany)
|
March 17, 2021
[Guideline for the Diagnosis and Treatment of Asthma - Addendum 2020 - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology]
R Buhl, R Bals, X Baur, et al.
The European Respiratory Journal
|
February 2, 2008
Outcomes for COPD pharmacological trials: from lung function to biomarkers
M Cazzola, W MacNee, F J Martinez, et al.
Page
of 65